Skip to main content

DSS, Inc.

corporate_fare Company Profile

DSS, Inc.

DSS·NYSE·Manufacturing·CIK 0000771999

DSS, Inc. operates four distinct business lines around the globe, with primary operations in North America and Asia: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Each business line is in various stages of development, growth, and income generation. Due to these variations in the business cycle, including differences in revenue and assets acquired, the Company currently reports financial information for four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. As other divisions grow and begin generating material operations and revenue, those operating segments may be added to financial segmental reporting. The Product Packaging division is led by wholly owned subsidiary Premier Packaging Corporation, Inc., a New York corporation. Premier operates in the paper board and fiber based folding carton, consumer product packaging, and document security printing markets. It markets, manufactures, and sells custom folding cartons, mailers, photo sleeves and complex 3-dimensional direct mail solutions. Premier is located in its new facility in Rochester, NY, and primarily serves the US market. The Biotechnology division is committed to both funding research and developing an intellectual property portfolio. It is currently focused on research in three main areas: (i) development of a universal therapeutic drug platform; (ii) a new sugar substitute; and (iii) a multi-use fragrance. Biotech discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.

DSS, Inc. (NYSE:DSS) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 2 items for DSS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for DSS spans 10-Q, DEF 14C.

Recent high-impact activity:

  • DSS 10-Q: Going Concern Warning, Revenue Down 44%, $39.1M Loan in Default
  • DSS Discloses Up to 42 Million Shares to Alset Under Four Related-Party Notes

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.76M
Net Income
-$23.93M
Op. Cash Flow
-$9.13M
Free Cash Flow
-$9.17M
Operating Income
-$14.43M
Cash & Equivalents
$6.21M
Total Debt
$5.73M
Debt / Equity
-6.88×
Net Margin
-115.3%
Shares Outstanding
9.09M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-014231

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 19,501 shares in DSS as of the October 30, 2026 settlement, a 62.2% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 1.3% of DSS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)19,501 shares as of October 30, 2026
Change vs prior period▼ 62.2%
Days to cover1.00 at avg daily volume of 29,359
Daily short volume (FINRA facilities)1.3% of 41,615 shares on November 20, 2026
5-day average short volume27.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for DSS, detected from its recent SEC filings · based on capital-structure filings through 2026-11-11.

Four Alset Issuances Approved by Written Consent · Dilution Roughly Four Times Current Shares

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

$0.49 -1.86% today
52-week range · as of 2026-11-13 $0.3605 – $1.86
Market cap
$4.52M
Volume
66.7K (1.4× avg)
3-mo avg 48.5K
Live data · 2026-11-22 12:33 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DSS - Latest Insights

DSS
Nov 13, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5252
Real-time Price: $0.490 info
Change: -$0.0352 (-7%) info
Market Cap: $4.519M info
DSS
Nov 10, 2026, 7:28 PM EST
Filing Type: DEF 14C
Importance Score:
8
Price at Filing: $0.4969
Real-time Price: $0.490 info
Change: -$0.0069 (-1%) info
Market Cap: $4.519M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets